Costs related to a Department of Justice investigation and restatement were $26.3 million this quarter, compared to $1.1 million in 2012. The company estimates the final resolution of the investigation could be $30 million.
The company’s total revenue was up slightly this quarter, from $91.7 million to $92.1 million. Second quarter product sales remained the same for both 2012 and 2013 at $87.5 million.
More Articles on Devices:
Mizuhow OSI Launches Software-Controlled Spinal Surgery Table
NDS Surgical Imaging Releases DomeAccess Software
ConforMIS Expands Series E Financing to $167M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
